Per Nilsson
1 – 10 of 118
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Prostate-specific antigen bounce after prostate ultra-hypofractionation: associations with 5-year outcomes in the phase 3 trial HYPO-RT-PC
    
    - Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
    (2025) 12th Øresund Workshop on Radiotherapy- Contribution to conference › Abstract
 
- 
                        Mark
        Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden
    
    - Contribution to journal › Article
 
- 
                        Mark
        Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume : A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
    
    - Contribution to journal › Article
 
- 
                        Mark
        Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
    (2024) U21 Health Sciences Group 2024 Doctoral Student Forum- Contribution to conference › Poster
 
- 
                        Mark
        Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
    (2024) Onkologidagarna 2024- Contribution to conference › Poster
 
- 
                        Mark
        Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
    
    - Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
    
    - Contribution to journal › Article
 
